CAMBRIDGE, Mass., April 6 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. today announced that its presentation at the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference will be webcast live and may be accessed by visiting the Investors section of the Company's website, http://www.millennium.com/ .
(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )
Millennium management will provide an overview of the Company and its pipeline and recent R&D developments. The presentation will be delivered at 1:20 P.M. ET on Wednesday, April 11, 2007 from the Millennium Broadway Hotel in New York, NY. The presentation will be archived for 30 days.
About Millennium
Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE(R) (bortezomib) for Injection, a novel cancer product, and has a robust clinical development pipeline of product candidates. The Company's research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium is developing an exciting pipeline of innovative product candidates. The Company's website is http://www.millennium.com/ .
Editors' Note: This press release is also available under the Media section of the Company's website at: http://www.millennium.com/ .
Contact:
Kyle Kuvalanka
(617) 761-4734
AP Archive: http://photoarchive.ap.org/
PRN Photo Desk,
